COVID-19 and Multiple Sclerosis Disease Modifying Therapies
Last updated on July 2021Recruitment
- Recruitment Status
- Enrolling by invitation
- Estimated Enrollment
- Same as current
Summary
- Conditions
- COVID-19
- Multiple Sclerosis
- Type
- Observational
- Design
- Observational Model: Case-ControlTime Perspective: Cross-Sectional
Participation Requirements
- Age
- Between 18 years and 125 years
- Gender
- Both males and females
Description
Not Provided
Not Provided
Tracking Information
- NCT #
- NCT04863586
- Collaborators
- Not Provided
- Investigators
- Principal Investigator: Nikos Evangelou, FRCP Nottingham University Hospitals NHS Trust